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Introduction 
 
 
Galectin-1 (Gal-1) is the first discovered, well characterized member of the galectin family. 
It can compose homodimer and has carbohydrate binding domain which recognizes 
glycosylated residues of proteins. Several different functions of Gal-1 were described. Its 
role in the development of olfactory neurons, axons was showed in experiments with mice. 
Gal-1 modifies the immune response by activation of Th2 cells which change the cytokine 
profile, so it reduces the inflammatory processes. In vivo Gal-1 is involved in induction of T 
and B cell apoptosis as well as it was identified as an effector molecule of regulatory T cells 
which initiate the programmed cell death of activated T cells during the elimination of 
immune response. The protein is important in maintaining of immune privilege developed 
by tumor cells. Gal-1 is able to bind to glycosylated residues of extracellular matrix proteins, 
so it influences adhesion processes. By means of this property, it can help migration of 
tumor cells and penetration through the blood vessel endothelium hereby forming metastasis. 
In normal, healthy organism the protein has precision controlling role, its relevance can be 
observed under pathological conditions. Lack of Gal-1 or its functional deficiency results in 
decreased immune modulator effect therefore chronic inflammation could be developed for 
example in case of rheumatoid arthritis or psoriasis. Increased activity of the protein is 
dangerous in tumor diseases because immune regulation could be stronger, progression of 
the tumor could be faster. The cells inside the growing tumor are under hypoxic conditions. 
These cells initiate formation of new blood vessels (angiogenesis) for surviving. Gal-1 
becomes activated in hypoxia and induces production of angiogenesis stimulating factors, 
hence it contributes to angiogenesis. 
Based on these findings we can say that Gal-1 is a very important, central molecule of tumor 
cells, it would be a good target for different tumor immunotherapy. 
It is strongly suggested that in vivo Gal-1 can develop its functions in solid phase (cell 
membrane or extracellular matrix) bound form since it binds glycoconjugates with high 
affinity that can be found in the environment of the cells. 
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Aims 
 
 
Most of the literature data about Gal-1 induced T cell apoptosis are known from different 
studies where soluble recombinant protein was used during the experiments. The aim of my 
work was to investigate the T cell apoptosis inducing ability of cell membrane bound Gal-1 
and examine the molecular mechanism of the programmed cell death. 
Following questions and tasks were defined: 
 
1.) developing an in vitro model system where the cell-cell interaction and apoptosis 
could be analyzed 
2.) to investigate the T cell apoptosis induced by tumor cells in cell culture 
3.) to describe whether tumor cell derived, membrane-bound Gal-1 is involved in 
triggering T cell apoptosis 
4.) to investigate the mechanism of T cell apoptosis induced by tumor cell derived Gal-1, 
and to compare this process to the main steps of soluble recombinant Gal-1 provoked 
T cell death 
 
 
Methods 
 
 
The presence of tumor cell produced Gal-1 on the cell membrane was detected by flow 
cytometry using anti-Gal-1 antibody produced in our laboratory. Measurements were 
evaluated by using CellQuestTM software. 
Cell-cell interaction was investigated by microscope, apoptosis was detected by using 
fluorescent dye-conjugated AnnexinV labeling. Involvement of p56lck and ZAP70 
kinases in apoptotic process was proved by enzyme deficient T cell lines. Mitochondrial 
membrane depolarization was showed by using JC-1 which is mitochondrial membrane 
potential-dependent dye. This molecule accumulates in the healthy mitochondria and 
then emits in red color, while it can not enter into the mitochondria with decreased 
membrane potential therefore only the green monomer form of the dye is visible in the 
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cytoplasm. Activation of caspase 3 in the T cells during the apoptotic pathway was 
proved by using an antibody which recognizes only the active, cleaved caspase 3. 
Gal-1 production in the cell lines was shown by Western blot. 
The Gal-1 non-expressing HeLa cells were transfected with Gal-1 cDNA containing 
pcDNA3.1 vector. The high amount of Gal-1 producing U87 glioma cells were 
transfected with pSUPERIOR-NEO plasmid wich encoded Gal-1 gene silencing siRNA 
sequence. Both transfections were performed with Ca3(PO4)2 mediated method. Stable 
clones were selected by neomycin resistance. 
 
 
Eredmények 
 
 
A special in vitro model system was developed in which we could investigate the 
interaction of tumor cells and T cells. The adherent glioma or melanoma cells were 
grown onto glass coverslip then activated T cells or Jurkat leukemic T cells which were 
used as model T cells were added and incubated in the same culture (co-culture). 
Previously the nuclei of T cells were labeled by Hoechst33342 dye for correct 
distinguishing. The staining did not influence the viability of the cells. Molecular 
mechanism of the T cell or Jurkat apoptosis was investigated in this system. We obtained 
the following results: 
 
1.) the examined Gal-1 expressing melanoma and glioma cells induced apoptosis of T 
cells in co-culture system in contrast to Gal-1 non-producing HeLa human cervix 
carcinoma cells 
2.) Gal-1 non-producing HeLa cells did not induce T cell apoptosis however they bound 
the exogenously added human recombinant Gal-1 on their cell surface. The elevated 
Gal-1 concentration resulted in more membrane bound protein and these HeLa cells 
were able to trigger T cell apoptosis, the ratio of dead T cells showed a good 
correlation with Gal-1 concentration 
3.) stable clones of Gal-1 cDNA transfected HeLa cells were selected, expressing 
different levels of Gal-1 protein. The percentage of T cell death induced by these 
cells was directly proportional to the amount of produced transgenic Gal-1. In 
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contrast the control HeLa cells which were transfected with empty plasmid did not 
induce apoptosis of T cells 
4.) although U87 glioblastoma cells produced large quantity of Gal-1 when this protein 
was removed from cell surface by thiodigalactoside (minimal ligand of the protein) 
the T cell apoptosis inducing ability was reduced 
5.) Gal-1 gene was silenced in U87 glioblastoma cells by siRNA technique (success was 
checked by flow cytometry and Western blot), decreased level of produced Gal-1 
resulted in diminished ratio of caused T cell death 
6.) since programmed death of T cells occured only in the presence of Gal-1 in co-
culture system we can conclude that Gal-1 was the main triggering factor of tumor 
cell induced T cell apoptosis 
7.) during our experiments which aimed to describe the mechanism of T cell death it 
was observed that concentrated supernatant of Gal-1 producing cell lines did not 
induce T cell apoptosis 
8.) when tumor cells and T cells were separated by a microporous membrane which 
inhibited the physical interaction of the two cell types but flowing of soluble factors 
was allowed, T cell apoptosis could not be detected 
9.) investigating the direct cell-cell interaction observed during co-culture experiments 
by confocal microscopy it was visible that Gal-1 protein translocated from tumor cell 
to the T cells 
10.) it is showed by these results that induction of T cell apoptosis required direct cell-
cell interaction between tumor and T cells when Gal-1 translocated from tumor cell 
to the T cells 
11.) p56lck and ZAP70 kinase deficient T cells were resistant to tumor cell induced cell 
death in co-culture system consequently these enzymes were involved in tumor cell 
derived Gal-1 triggered apoptosis 
12.) one of the most characteristic marker of the apoptosis is the translocation of 
phosphatidil-serin from intracellular side of the cell membrane to the extracellular 
surface, we detected this phenomenon by labeling with flurescent dye-conjugated 
AnnexinV 
13.) mitochondrial membrane depolarization was observed in T cells co-cultured with 
Gal-1 expressing tumor cells by using a special, mitochondrial membrane potential-
dependent dye which indicates decreasing of membrane potential by color changing 
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14.) activation of caspase 3 was detected in apoptotic T cells using an antibody which 
recognize only the cleaved, active enzyme 
15.) accordingly, molecular mechanism of tumor cell-derived Gal-1 induced T cell 
apoptosis corresponded with main steps of recombinant Gal-1 caused programmed T 
cell death which have published earlier by our group 
 
 
Based on our findings we can conclude that Gal-1 producing tumor cells induce apoptosis of 
co-cultured T cells in contrast to Gal-1 non-expressing tumor cells. Direct cell-cell 
interaction is required for apoptosis induction, where Gal-1 translocates from tumor cell to T 
cell. Gal-1 produced by tumor cells triggers T cell apoptosis via similar molecular pathway 
as we described before in case of recombinant Gal-1. 
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